Novo Nordisk's (DK:NOVO.B) next-gen medication is called CagriSema. It's a once-weekly shot that combines a long-acting amylin analogue and Wegovy. Clinical trials found that patients taking CagriSema ...
A selective androgen receptor modulator combined with a GLP-1 may induce weight loss for older adults with obesity while ...
Dozens of felony cases have crumbled in DOJ's push to punish protesters ...
President Trump launched TrumpRx, a new initiative aiming to slash prescription drug costs by forging direct deals with ...